KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bionano Genomics (BNGO) Accumulated Expenses (2017 - 2025)

Bionano Genomics (BNGO) has disclosed Accumulated Expenses for 9 consecutive years, with $4.7 million as the latest value for Q3 2025.

  • Quarterly Accumulated Expenses fell 20.01% to $4.7 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $4.7 million through Sep 2025, down 20.01% year-over-year, with the annual reading at $5.6 million for FY2024, 30.26% down from the prior year.
  • Accumulated Expenses hit $4.7 million in Q3 2025 for Bionano Genomics, up from $3.4 million in the prior quarter.
  • In the past five years, Accumulated Expenses ranged from a high of $11.7 million in Q3 2022 to a low of $3.4 million in Q2 2025.
  • Historically, Accumulated Expenses has averaged $7.7 million across 5 years, with a median of $8.1 million in 2023.
  • Biggest five-year swings in Accumulated Expenses: skyrocketed 169.03% in 2021 and later plummeted 64.3% in 2025.
  • Year by year, Accumulated Expenses stood at $8.6 million in 2021, then grew by 22.4% to $10.6 million in 2022, then decreased by 23.34% to $8.1 million in 2023, then plummeted by 30.26% to $5.6 million in 2024, then decreased by 16.58% to $4.7 million in 2025.
  • Business Quant data shows Accumulated Expenses for BNGO at $4.7 million in Q3 2025, $3.4 million in Q2 2025, and $3.9 million in Q1 2025.